Masitinib in Patients With Mild Alzheimer's Disease

Clinical trial NCT05564169 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05564169
Sponsor: AB Science
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2026-06-01
Primary completion: 2028-12-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.